Amgen/AstraZeneca’s Tezspire Shows Efficacy In Broader COPD Population

Phase III Planning Under Way

 
• By Mandy Jackson
Human Respiratory System Lungs Anatomy. Man silhouette healthy lungs medicine model.
Tezspire showed greater efficacy in COPD patients with blood eosinophil counts of 150 or greater • Source: Shutterstock

More from Clinical Trials

More from R&D